Profile: Medicago is a biotechnology company. We focus on the development, production and supply of protein based vaccines & biopharmaceuticals. We also develop transient expression system which produces recombinant vaccine antigens in the cells of non-transgenic plants that offer significant advantages of speed over competitive egg-based and cell culture technologies. We also develop a virus-like particle vaccine candidate for H5N1 avian influenza that enhances immunity and therefore increases the protection against disease.